222 related articles for article (PubMed ID: 17929014)
21. Three-dimensional radiobiological dosimetry (3D-RD) with 124I PET for 131I therapy of thyroid cancer.
Sgouros G; Hobbs RF; Atkins FB; Van Nostrand D; Ladenson PW; Wahl RL
Eur J Nucl Med Mol Imaging; 2011 May; 38 Suppl 1(Suppl 1):S41-7. PubMed ID: 21484384
[TBL] [Abstract][Full Text] [Related]
22. [Comparison of activity expression between PET using 68Ge-68Ga line source attenuation correction and PET-CT using CT attenuation correction: impact on emission images].
Hayashi E; Iwase M; Kojima S; Nishio M
Nihon Hoshasen Gijutsu Gakkai Zasshi; 2006 Jun; 62(6):832-9. PubMed ID: 16799411
[TBL] [Abstract][Full Text] [Related]
23. Comparison of two commercial whole body PET systems based on LSO and BGO crystals respectively for brain imaging.
Trébossen R; Comtat C; Brulon V; Bailly P; Meyer ME
Med Phys; 2009 Apr; 36(4):1399-409. PubMed ID: 19472647
[TBL] [Abstract][Full Text] [Related]
24. [Improvement of quantitative accuracy using phase-based respiratory-gated PET/CT in phantom and clinical studies].
Miwa K; Wagatsuma K; Umeda T; Miyaji N; Murata T; Osawa A; Takiguchi T; Koizumi M; Sasaki M
Nihon Hoshasen Gijutsu Gakkai Zasshi; 2014 Nov; 70(11):1235-42. PubMed ID: 25410329
[TBL] [Abstract][Full Text] [Related]
25. Comparison of dedicated breast positron emission tomography and whole-body positron emission tomography/computed tomography images: a common phantom study.
Satoh Y; Motosugi U; Imai M; Onishi H
Ann Nucl Med; 2020 Feb; 34(2):119-127. PubMed ID: 31768819
[TBL] [Abstract][Full Text] [Related]
26. On the quantification accuracy, homogeneity, and stability of simultaneous positron emission tomography/magnetic resonance imaging systems.
Schmidt H; Schwenzer NF; Bezrukov I; Mantlik F; Kolb A; Kupferschläger J; Pichler BJ
Invest Radiol; 2014 Jun; 49(6):373-81. PubMed ID: 24368614
[TBL] [Abstract][Full Text] [Related]
27. Technical Note: Transconvolution based equalization of positron energy effects for the use of
Prenosil GA; Hentschel M; Fürstner M; Krause T; Weitzel T; Klaeser B
Med Phys; 2017 Jul; 44(7):3761-3766. PubMed ID: 28494090
[TBL] [Abstract][Full Text] [Related]
28. Partial-volume correction in PET: validation of an iterative postreconstruction method with phantom and patient data.
Teo BK; Seo Y; Bacharach SL; Carrasquillo JA; Libutti SK; Shukla H; Hasegawa BH; Hawkins RA; Franc BL
J Nucl Med; 2007 May; 48(5):802-10. PubMed ID: 17475970
[TBL] [Abstract][Full Text] [Related]
29. Whole-remnant and maximum-voxel SPECT/CT dosimetry in
Mínguez P; Flux G; Genollá J; Delgado A; Rodeño E; Sjögreen Gleisner K
Med Phys; 2016 Oct; 43(10):5279. PubMed ID: 27782699
[TBL] [Abstract][Full Text] [Related]
30. Accurate dosimetry in 131I radionuclide therapy using patient-specific, 3-dimensional methods for SPECT reconstruction and absorbed dose calculation.
Dewaraja YK; Wilderman SJ; Ljungberg M; Koral KF; Zasadny K; Kaminiski MS
J Nucl Med; 2005 May; 46(5):840-9. PubMed ID: 15872359
[TBL] [Abstract][Full Text] [Related]
31. (90)Y-PET/CT Imaging Quantification for Dosimetry in Peptide Receptor Radionuclide Therapy: Analysis and Corrections of the Impairing Factors.
Fabbri C; Bartolomei M; Mattone V; Casi M; De Lauro F; Bartolini N; Gentili G; Amadori S; Agostini M; Sarti G
Cancer Biother Radiopharm; 2015 Jun; 30(5):200-10. PubMed ID: 25860616
[TBL] [Abstract][Full Text] [Related]
32. Is the image quality of I-124-PET impaired by an automatic correction of prompt gammas?
Preylowski V; Schlögl S; Schoenahl F; Jörg G; Samnick S; Buck AK; Lassmann M
PLoS One; 2013; 8(8):e71729. PubMed ID: 24014105
[TBL] [Abstract][Full Text] [Related]
33. Assessment of the short-lived non-pure positron-emitting nuclide (120)I for PET imaging.
Herzog H; Qaim SM; Tellmann L; Spellerberg S; Kruecker D; Coenen HH
Eur J Nucl Med Mol Imaging; 2006 Nov; 33(11):1249-57. PubMed ID: 16845512
[TBL] [Abstract][Full Text] [Related]
34. Absolute quantification of activity content from PET images using the Philips Gemini TF PET/CT system.
Sydoff M; Uusijärvi H; Leide-Svegborn S; Mattsson S
Radiat Prot Dosimetry; 2010; 139(1-3):236-9. PubMed ID: 20223853
[TBL] [Abstract][Full Text] [Related]
35. Measuring PET Spatial Resolution Using a Cylinder Phantom Positioned at an Oblique Angle.
Lodge MA; Leal JP; Rahmim A; Sunderland JJ; Frey EC
J Nucl Med; 2018 Nov; 59(11):1768-1775. PubMed ID: 29903932
[TBL] [Abstract][Full Text] [Related]
36. A gate evaluation of the sources of error in quantitative
Strydhorst J; Carlier T; Dieudonné A; Conti M; Buvat I
Med Phys; 2016 Oct; 43(10):5320-5329. PubMed ID: 28105711
[TBL] [Abstract][Full Text] [Related]
37. NEMA NU 2-2001 performance measurements of an LYSO-based PET/CT system in 2D and 3D acquisition modes.
Kemp BJ; Kim C; Williams JJ; Ganin A; Lowe VJ;
J Nucl Med; 2006 Dec; 47(12):1960-7. PubMed ID: 17138738
[TBL] [Abstract][Full Text] [Related]
38. (90)Y -PET imaging: Exploring limitations and accuracy under conditions of low counts and high random fraction.
Carlier T; Willowson KP; Fourkal E; Bailey DL; Doss M; Conti M
Med Phys; 2015 Jul; 42(7):4295-309. PubMed ID: 26133627
[TBL] [Abstract][Full Text] [Related]
39. RADIOISOTOPE DIAGNOSTIC ALGORITHM FOR THE RELAPSE AND METASTASES DETECTION IN THE IODINE-NEGATIVE DIFFERENTIATED THYROID CANCER.
Solodyannikova OI; Kmetyuk YV; Danilenko VV; Sukach GG
Probl Radiac Med Radiobiol; 2020 Dec; 25():579-591. PubMed ID: 33361863
[TBL] [Abstract][Full Text] [Related]
40. Clinical applications of 124I-PET/CT in patients with differentiated thyroid cancer.
Freudenberg LS; Jentzen W; Stahl A; Bockisch A; Rosenbaum-Krumme SJ
Eur J Nucl Med Mol Imaging; 2011 May; 38 Suppl 1():S48-56. PubMed ID: 21484380
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
